Citation: | DENG Chenghao, CHEN Kangyu, WANG Qi, WU Guohong, YAN Ji. Association of holter monitoring (24-hour ECG) parameters with improvement in left ventricular ejection fraction in heart failure with reduced ejection fraction[J]. Chinese Journal of General Practice, 2023, 21(4): 572-575. doi: 10.16766/j.cnki.issn.1674-4152.002933 |
[1] |
FANG S C, WU Y L, TSAI P S. Heart rate variability and risk of all-cause death and cardiovascular events in patients with cardiovascular disease: a meta-analysis of cohort studies[J]. Biol Res Nurs, 2020, 22(1): 45-56. doi: 10.1177/1099800419877442
|
[2] |
BOAS R, THUNE J J, PEHRSON S, et al. Prevalence and prognostic association of ventricular arrhythmia in non-ischaemic heart failure patients: results from the DANISH trial[J]. Europace, 2021, 23(4): 587-595. doi: 10.1093/europace/euaa341
|
[3] |
CORREALE M, MALLARDI A, TRICARICO L, et al. Remodelling is inversely proportional to left ventricular dimensions in a real-life population of patients with chronic heart failure after therapy with sacubitril/valsartan[J]. Acta Cardiol, 2022, 77(5): 416-421. doi: 10.1080/00015385.2021.1950371
|
[4] |
SHAH M A, SOOFI M A, JAFARY Z, et al. Echocardiographic parameters associated with recovery in heart failure with reduced ejection fraction[J]. Echocardiography, 2020, 37(10): 1574-1582. doi: 10.1111/echo.14859
|
[5] |
NISHIMURA S, IZUMI C, HIMURA Y, et al. Very long-term follow-up data of non-ischemic idiopathic dilated cardiomyopathy after beta-blocker therapy: recurrence of left ventricular dysfunction and predictive value of 123Ⅰ-metaiodobenzylguanidine scintigraphy[J]. Heart Vessels, 2019, 34(2): 259-267. doi: 10.1007/s00380-018-1245-y
|
[6] |
WILCOX J E, FANG J C, MARGULIES K B, et al. Heart failure with recovered left ventricular ejection fraction: JACC scientific expert panel[J]. J Am Coll Cardiol, 2020, 76(6): 719-734. doi: 10.1016/j.jacc.2020.05.075
|
[7] |
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789. doi: 10.3760/cma.j.issn.0253-3758.2018.10.004
Heart Failure Group of Chinese Society of Cardiology of Chinese Medical Association, Chinese Heart Failure Association of Chinese Medical Doctor Association, Editorial Board of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and treatment of heart failure 2018[J]. Chinese Journal of Cardiology, 2018, 46(10): 760-789. doi: 10.3760/cma.j.issn.0253-3758.2018.10.004
|
[8] |
2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines[J]. Circulation, 2022, 145(18): e1033. DOI:
|
[9] |
谢彩侠, 宣玲, 康品方, 等. 沙库巴曲缬沙坦对慢性心力衰竭患者血心室重塑相关指标及心功能的影响[J]. 中华全科医学, 2022, 20(12): 2010-2014. doi: 10.16766/j.cnki.issn.1674-4152.002757
XIE C X, XUAN L, KANG P F, et al. Influence of sacubitril / valsartan on related indexes of ventricular remodeling and cardiac function in patients with chronic heart failure[J]. Chinese Journal of General Practice, 2022, 20(12): 2010-2014. doi: 10.16766/j.cnki.issn.1674-4152.002757
|
[10] |
REINHARDT S W, CHOUAIRI F, MILLER P E, et al. National trends in the burden of atrial fibrillation during hospital admissions for heart failure[J]. J Am Heart Assoc, 2021, 10(11): e019412. DOI: 10.1161/JAHA.120.019412.
|
[11] |
MULDER B A, RIENSTRA M, BLAAUW Y. Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction[J]. Heart, 2021, 107(1): 10-17. doi: 10.1136/heartjnl-2020-317491
|
[12] |
CARLISLE M A, FUDIM M, DEVORE A D, et al. Heart failure and atrial fibrillation, like fire and fury[J]. JACC Heart Fail, 2019, 7(6): 447-456. doi: 10.1016/j.jchf.2019.03.005
|
[13] |
周阿培, 陈东, 胡凯, 等. 冷冻球囊消融治疗心房颤动合并心力衰竭患者临床疗效观察[J]. 中华全科医学, 2022, 20(2): 228-232. doi: 10.16766/j.cnki.issn.1674-4152.002319
ZHOU A P, CHEN D, HU K, et al. Clinical effect of cryoballoon catheter ablation in patients with atrial fibrillation Combining with heart failure[J]. Chinese Journal of General Practice, 2022, 20(2): 228-232. doi: 10.16766/j.cnki.issn.1674-4152.002319
|
[14] |
TIWARI R, KUMAR R, MALIK S, et al. Analysis of heart rate variability and implication of different factors on heart rate variability[J]. Curr Cardiol Rev, 2021, 17(5): e160721189770. DOI: 10.2174/1573403X16999201231203854.
|
[15] |
DZIKOWICZ D J, CAREY M G. Correlates of autonomic function, hemodynamics, and physical activity performance during exercise stress testing among firefighters[J]. Biol Res Nurs, 2022. DOI: 10.1177/10998004221143508.
|
[16] |
KUBOTA Y, CHEN L Y, WHITSEL E A, et al. Heart rate variability and lifetime risk of cardiovascular disease: the Atherosclerosis Risk in Communities Study[J]. Ann Epidemiol, 2017, 27(10): 619-625. e2. doi: 10.1016/j.annepidem.2017.08.024
|
[17] |
GOULART C L, CARUSO F R, ARÊAS G P T, et al. Impact of chronic obstructive pulmonary disease on linear and nonlinear dynamics of heart rate variability in patients with heart failure[J]. Braz J Med Biol Res, 2020, 54(2): e10084. DOI: 10.1590/1414-431X202010084.
|
[18] |
GUERRA L A, LTEIF C, ARWOOD M J, et al. Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers[J]. Pharmacogenomics J, 2022, 22(1): 62-68. doi: 10.1038/s41397-021-00257-1
|